F06.7
Conditions
Interventions
Group 1: Longitudinal study of patients (w/m) with subjectively perceived memory impairment. Patients are asked at specific timepoints about the user experience and the evaluation of the added value o
Sponsors
Roche Pharma AG
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients who have a subjectively perceived memory disorder and therefore present to a participating physician can be included. The memory problem can be raised by the patients themselves, by relatives or by the physicians. The participating physicians decide independently and together with the respective patients whether the app neotivCare is recommended for them.
Exclusion criteria
Exclusion criteria: No direct exclusion criteria are defined. Indirect exclusion criteria arise if the patient rejects the prescription recommendation or if medical, social or technical reasons prevent further participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Satisfaction with the neotivCare app compared to standard procedures from the point of view of physicians and patients. Neuropsychological questionnaires and scores such as the Mini-Mental Status Test (MMST), the DemTec Test, the Montreal Cognitive Assessment Test (MoCA), the Clock Drawing Test, the Consortium to Establish a Registry for Alzheimer's Disease Test (CERAD), the Preclinical Alzheimer's Cognitive Composite Score (PACC) and others are considered standard procedures. | — |
Secondary
| Measure | Time frame |
|---|---|
| Added value, user-friendliness and acceptance of the app as well as effects of the app in physician networks. | — |
Countries
Germany
Contacts
Public ContactMichael Schöttler
Roche Pharma AG
Outcome results
None listed